Annual Results 2021 - Feb 02, 2022
English (PDF 0.3 MB) | Deutsch (PDF 0.3 MB) | Français (PDF 0.3 MB)
Condensed financial report (PDF 0.5 MB)
Webcast and presentation
Download the podcast (MP3 43 MB)
Read the presentation transcript
Download the presentation (PDF 4.9 MB)
Novartis ESG Update - February 03, 2022 (PDF 1.7 MB)
Annual Report and US Securities & Exchange Commission Form 20-F
These reports, filed with the SIX Swiss Exchange in Switzerland and the US Securities and Exchange Commission (SEC) in the US, provide a comprehensive overview of Novartis, including our company structure, corporate governance and compensation practices. They also disclose our operating and financial results, accompanied by audited annual financial statements.
Download the Novartis Annual Report 2021 (SIX filing) (PDF 3.4 MB)
Download the Novartis Form 20-F for 2021 (SEC filing) (PDF 3.3 MB)
Download Amendment No. 1 to Novartis Form 20-F for 2021 (dated April 26, 2022 | PDF 0.2 MB)
To request a hard copy of the Annual Report and/or SEC Form 20-F, fill out the order form.